CLAVAMOX Side Effects

7022844-2 | Back Pain, Chest Pain, Ecchymosis, Localised Oedema, Oedema Peripheral, Periorbital Oedema, Pyrexia, Rash
on Sep 21, 2010 Female patient from PORTUGAL , child 3 years of age, was diagnosed with tonsillitis and was treated with Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), chest pain (What is chest pain?), ecchymosis, localised oedema, oedema peripheral, periorbital oedema, pyrexia, rash (What is rash?). Clavamox dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6970877-4 | Hepatic Function Abnormal
Patient was taking Clavamox (View Usage). Patient had the following side effects: hepatic function abnormal on Sep 01, 2010 from JAPAN Additional patient health information: Male patient , child 7 years of age, . Clavamox dosage: 3iuax Per Day. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6857109-2 | Abnormal Behaviour
Adverse event was reported on Jul 12, 2010 by a Male patient taking Clavamox (View Usage) (Dosage: 3.03g Per Day) was diagnosed with otitis media acute and. Location: JAPAN , weighting 41.89 lb, After Clavamox was administered, patient had the following side effects: abnormal behaviour. During the same period patient was treated with ZADITEN (1.4g Per Day) (View Zaditen Review and Zaditen Label ), MUCODYNE (1.2g Per Day) (View Mucodyne Review and Mucodyne Label ), CEFDINIR (View Cefdinir Review and Cefdinir Label ).

6795972-4 |
on Jun 14, 2010 Female patient from PORTUGAL , 70 years of age, was treated with Clavamox (View Usage). . Clavamox dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VOLTAREN (View Voltaren Review and Voltaren Label ).


6686450-1 | Angioedema, Epstein-barr Virus Infection, Infectious Mononucleosis, Purpura, Rash Maculo-papular
on Apr 12, 2010 Male patient from AUSTRIA , 26 years of age, weighting 187.4 lb, was diagnosed with oropharyngeal pain and was treated with Clavamox (View Usage). Patient had the following side effects: angioedema, epstein-barr virus infection, infectious mononucleosis (What is infectious mononucleosis?), purpura, rash maculo-papular. Clavamox dosage: . During the same period patient was treated with STREPSILS (View Strepsils Review and Strepsils Label ). Patient was hospitalized.

6681406-7 | Chills, Dermatitis Exfoliative, Eosinophilia, Transaminases Increased
Patient was taking Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: chills, dermatitis exfoliative, eosinophilia, transaminases increased on Apr 07, 2010 from AUSTRIA Additional patient health information: Male patient , 27 years of age, weighting 209.4 lb, was diagnosed with tympanic membrane perforation and. Clavamox dosage: 1g Single Dose. Patient was hospitalized.

6677498-1 | Chills, Dermatitis Exfoliative, Eosinophilia, Transaminases Increased
Adverse event was reported on Apr 02, 2010 by a Male patient taking Clavamox (View Usage) (Dosage: 1g Single Dose) was diagnosed with tympanic membrane perforation and. Location: AUSTRIA , 27 years of age, weighting 209.4 lb, Patient experienced the following unwanted or unexpected effects: chills, dermatitis exfoliative, eosinophilia, transaminases increased. Patient was hospitalized.

6677497-X | Epstein-barr Virus Infection, Hepatic Enzyme Increased, Rash Macular, Rash Pruritic, Skin Disorder, Splenomegaly
on Apr 02, 2010 Male patient from AUSTRIA , 16 years of age, weighting 200.6 lb, was diagnosed with nasopharyngitis and was treated with Clavamox (View Usage). Patient had the following side effects: epstein-barr virus infection, hepatic enzyme increased, rash macular, rash pruritic, skin disorder, splenomegaly. Clavamox dosage: 1g Three Times Per Day. Patient was hospitalized.

6643014-3 | Diarrhoea, Haematochezia, Pseudomembranous Colitis
on Mar 09, 2010 Male patient from JAPAN , child 1 years of age, was treated with Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: diarrhoea, haematochezia, pseudomembranous colitis. Clavamox dosage: . During the same period patient was treated with LEBENIN (View Lebenin Review and Lebenin Label ), ACDEAM (View Acdeam Review and Acdeam Label ), MEDICON (View Medicon Review and Medicon Label ).

6613948-4 | Oral Mucosa Erosion, Rash Maculo-papular
Patient was taking Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: oral mucosa erosion, rash maculo-papular on Feb 24, 2010 from AUSTRIA Additional patient health information: Male patient , 38 years of age, weighting 275.6 lb, . Clavamox dosage: . During the same period patient was treated with DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

6612089-X | Heparin-induced Thrombocytopenia, Rash Maculo-papular
Adverse event was reported on Feb 24, 2010 by a Male patient taking Clavamox (View Usage) (Dosage: 625mg Three Times Per Day) was diagnosed with thrombosis prophylaxis, heparin-induced thrombocytopenia and. Location: AUSTRIA , 70 years of age, weighting 121.3 lb, Patient had the following side effects: heparin-induced thrombocytopenia, rash maculo-papular. During the same period patient was treated with LOVENOX (40mg Per Day) (View Lovenox Review and Lovenox Label ), ORGARAN (View Orgaran Review and Orgaran Label ). Patient was hospitalized.

6612088-8 | Angioedema, Blood Pressure Fluctuation, Dyspnoea, Hypersensitivity, Infection, Sinusitis
on Feb 24, 2010 Female patient from AUSTRIA , 30 years of age, was diagnosed with toothache and was treated with Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: angioedema, blood pressure fluctuation, dyspnoea, hypersensitivity, infection (What is infection?), sinusitis (What is sinusitis?). Clavamox dosage: 1mg Per Day. Patient was hospitalized.

6597069-5 | Epstein-barr Virus Test Positive, Face Oedema, Infectious Mononucleosis, Lymphadenopathy, Lymphocyte Count Increased, Lymphocyte Morphology Abnormal, Pharyngeal Erythema, Pyrexia, Rash
on Feb 15, 2010 Male patient from JAPAN , child 3 years of age, was treated with Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: epstein-barr virus test positive, face oedema, infectious mononucleosis (What is infectious mononucleosis?), lymphadenopathy, lymphocyte count increased, lymphocyte morphology abnormal, pharyngeal erythema, pyrexia, rash (What is rash?). Clavamox dosage: . Patient was hospitalized.

6407315-6 | Blister, Blood Creatinine Decreased, C-reactive Protein Increased, Cyst, Decreased Appetite, Erythema, Eyelid Oedema
Patient was taking Clavamox (View Usage). Patient had the following side effects: blister, blood creatinine decreased, c-reactive protein increased, cyst, decreased appetite, erythema, eyelid oedema on Oct 13, 2009 from JAPAN Additional patient health information: Male patient , weighting 33.07 lb, was diagnosed with wound (What is wound?) and. Clavamox dosage: . During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), GARASONE (View Garasone Review and Garasone Label ), ZADITEN (View Zaditen Review and Zaditen Label ), BANAN (View Banan Review and Banan Label ), KLARICID (View Klaricid Review and Klaricid Label ). Patient was hospitalized.

6390234-1 | Blister, Blood Creatinine Decreased, C-reactive Protein Increased, Cyst, Decreased Appetite, Erythema, Eyelid Oedema, Haemoglobin Decreased
Adverse event was reported on Sep 29, 2009 by a Male patient taking Clavamox (View Usage) (Dosage: ) was diagnosed with wound (What is wound?) and. Location: JAPAN , weighting 33.07 lb, After Clavamox was administered, patient had the following side effects: blister, blood creatinine decreased, c-reactive protein increased, cyst, decreased appetite, erythema, eyelid oedema, haemoglobin decreased. During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), GARASONE (View Garasone Review and Garasone Label ), ZADITEN (View Zaditen Review and Zaditen Label ), BANAN (View Banan Review and Banan Label ), KLARICID (View Klaricid Review and Klaricid Label ). Patient was hospitalized.

6339331-7 | Pyrexia
on Aug 26, 2009 Female patient from JAPAN , child 1 years of age, was treated with Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia. Clavamox dosage: . Patient was hospitalized.

6313326-1 | Blister, Blood Creatinine Decreased, C-reactive Protein Increased, Cyst, Decreased Appetite, Erythema, Eyelid Oedema, Haemoglobin Decreased
on Aug 11, 2009 Male patient from JAPAN , weighting 33.07 lb, was diagnosed with wound (What is wound?) and was treated with Clavamox (View Usage). Patient had the following side effects: blister, blood creatinine decreased, c-reactive protein increased, cyst, decreased appetite, erythema, eyelid oedema, haemoglobin decreased. Clavamox dosage: . During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), GARASONE (View Garasone Review and Garasone Label ), ZADITEN (View Zaditen Review and Zaditen Label ), BANAN (View Banan Review and Banan Label ), KLARICID (View Klaricid Review and Klaricid Label ). Patient was hospitalized.

6261912-X | Erythema Multiforme
Patient was taking Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: erythema multiforme on Jul 01, 2009 from JAPAN Additional patient health information: Male patient , weighting 24.25 lb, was diagnosed with otitis media acute and. Clavamox dosage: . Patient was hospitalized.

6231530-8 | Hypotension, Loss Of Consciousness, Nausea, Vertigo
Adverse event was reported on Jun 10, 2009 by a Male patient taking Clavamox (View Usage) (Dosage: 1g Per Day) was diagnosed with acute tonsillitis and. Location: AUSTRIA , weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: hypotension, loss of consciousness, nausea (What is nausea?), vertigo. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ).

6119546-3 | Convulsion, Tremor
on Mar 11, 2009 Female patient from JAPAN , child 3 years of age, was diagnosed with otitis media acute and was treated with Clavamox (View Usage). Patient had the following side effects: convulsion, tremor. Clavamox dosage: . During the same period patient was treated with BIOFERMIN (3g Per Day) (View Biofermin Review and Biofermin Label ).

6087366-4 | Rash
on Feb 17, 2009 Female patient from JAPAN , child 3 years of age, was diagnosed with otitis media and was treated with Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: rash (What is rash?). Clavamox dosage: .

6064578-7 | Dyspnoea, Face Oedema, Wheezing
Patient was taking Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, face oedema, wheezing on Feb 02, 2009 from PORTUGAL Additional patient health information: Female patient , 20 years of age, weighting 143.3 lb, . Clavamox dosage: 1000mg Per Day. During the same period patient was treated with ALPHA AMYLASE (9000iu Per Day) (View Alpha Amylase Review and Alpha Amylase Label ). Patient was hospitalized.

6037284-2 | Dyspnoea, Face Oedema, Wheezing
Adverse event was reported on Jan 09, 2009 by a Female patient taking Clavamox (View Usage) (Dosage: 1000mg Per Day) . Location: PORTUGAL , 20 years of age, weighting 121.3 lb, Patient had the following side effects: dyspnoea, face oedema, wheezing. During the same period patient was treated with ALPHA AMYLASE (9000iu Per Day) (View Alpha Amylase Review and Alpha Amylase Label ). Patient was hospitalized.

6034438-6 | Convulsion
on Jan 09, 2009 Female patient from JAPAN , child 2 years of age, was diagnosed with otitis media and was treated with Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: convulsion. Clavamox dosage: .

5987035-2 | Pyrexia, Rash Maculo-papular, Toxic Skin Eruption
on Nov 28, 2008 Female patient from SWITZERLAND , 33 years of age, was diagnosed with cough and was treated with Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia, rash maculo-papular, toxic skin eruption. Clavamox dosage: . During the same period patient was treated with ELOCON (View Elocon Review and Elocon Label ). Patient was hospitalized.

5939097-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Hepatic Function Abnormal, Jaundice, Liver Disorder, Pyrexia, Rash
Patient was taking Clavamox (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hepatic function abnormal, jaundice (What is jaundice?), liver disorder, pyrexia, rash (What is rash?) on Oct 28, 2008 from JAPAN Additional patient health information: Female patient , child 1 years of age, weighting 22.49 lb, was diagnosed with otitis media and. Clavamox dosage: 48.2mgk Twice Per Day. Patient was hospitalized.

5928074-7 | Blood Alkaline Phosphatase Increased, Blood Creatinine Decreased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Erythema, Lymphocyte Count Increased, Monocyte Count Decreased, Neutrophil Count Decreased
Adverse event was reported on Oct 20, 2008 by a Female patient taking Clavamox (View Usage) (Dosage: 1.05g Twice Per Day) was diagnosed with otitis media and. Location: JAPAN , child 3 years of age, weighting 31.53 lb, After Clavamox was administered, patient had the following side effects: blood alkaline phosphatase increased, blood creatinine decreased, blood lactate dehydrogenase increased, c-reactive protein increased, erythema, lymphocyte count increased, monocyte count decreased, neutrophil count decreased. During the same period patient was treated with MUCODYNE (1.2g Per Day) (View Mucodyne Review and Mucodyne Label ), ZADITEN (1.2g Per Day) (View Zaditen Review and Zaditen Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), ENTERONON R (1.35g Per Day) (View Enteronon-r Review and Enteronon-r Label ), ALBUMIN TANNATE (.9g Per Day) (View Albumin Tannate Review and Albumin Tannate Label ), ADSORBIN (.9g Per Day) (View Adsorbin Review and Adsorbin Label ). Patient was hospitalized.

5926618-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Hepatic Function Abnormal, Liver Disorder
on Oct 16, 2008 Female patient from JAPAN , child 1 years of age, weighting 22.49 lb, was diagnosed with otitis media and was treated with Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hepatic function abnormal, liver disorder. Clavamox dosage: 48.2mgk Twice Per Day. Patient was hospitalized.

5893307-2 | Altered State Of Consciousness, Convulsion
on Sep 18, 2008 Male patient from JAPAN , child 1 years of age, was diagnosed with otitis media and was treated with Clavamox (View Usage). Patient had the following side effects: altered state of consciousness, convulsion. Clavamox dosage: . During the same period patient was treated with ERYTHROCIN (View Erythrocin Review and Erythrocin Label ). Patient was hospitalized.

5832315-4 | Anorexia, Pyrexia
Patient was taking Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: anorexia, pyrexia on Jul 28, 2008 from JAPAN Additional patient health information: Female patient , child 1 years of age, weighting 19.84 lb, was diagnosed with otitis media acute, cough and. Clavamox dosage: .7g Twice Per Day. During the same period patient was treated with HOKUNALIN (.5mg Per Day) (View Hokunalin Review and Hokunalin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALIMEZINE (3ml Per Day) (View Alimezine Review and Alimezine Label ), MUCODYNE (3.99ml Per Day) (View Mucodyne Review and Mucodyne Label ), ASVERIN (3ml Per Day) (View Asverin Review and Asverin Label ).

5757060-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Helicobacter Infection, Hepatic Failure, Hypersensitivity, Rash
Adverse event was reported on May 27, 2008 by a Male patient taking Clavamox (View Usage) (Dosage: 1g Twice Per Day) . Location: AUSTRIA , 76 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, helicobacter infection, hepatic failure, hypersensitivity, rash (What is rash?). During the same period patient was treated with METRONIDAZOLE (500mg Twice Per Day) (View Metronidazole Review and Metronidazole Label ), CLARITHROMYCIN (500mg Twice Per Day) (View Clarithromycin Review and Clarithromycin Label ), PROTON PUMP INHIBITOR (View Proton Pump Inhibitor Review and Proton Pump Inhibitor Label ). Patient was hospitalized.

5675927-3 | Eczema, Hepatic Enzyme Increased, Pruritus, Skin Erosion, Swelling
on Mar 18, 2008 Female patient from JAPAN , child 5 years of age, was treated with Clavamox (View Usage). Patient had the following side effects: eczema (What is eczema?), hepatic enzyme increased, pruritus, skin erosion, swelling. Clavamox dosage: .

5643000-6 | Angioedema, Circumoral Oedema, Erythema
on Feb 20, 2008 Female patient from PORTUGAL , 78 years of age, weighting 143.3 lb, was diagnosed with respiratory tract infection, epilepsy (What is epilepsy?) and was treated with Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: angioedema, circumoral oedema, erythema. Clavamox dosage: . During the same period patient was treated with SENSODYNE F (View Sensodyne-f Review and Sensodyne-f Label ), MANNITOL (View Mannitol Review and Mannitol Label ), SENNA EXTRACT (View Senna Extract Review and Senna Extract Label ), PHENYTOIN SODIUM (225mg Per Day) (View Phenytoin Sodium Review and Phenytoin Sodium Label ), NICERGOLINE (20mg Per Day) (View Nicergoline Review and Nicergoline Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ).

5451429-4 | Condition Aggravated, Erythema, Pruritus, Rash Papular, Skin Exfoliation
Patient was taking Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, erythema, pruritus, rash papular, skin exfoliation on Sep 06, 2007 from PORTUGAL Additional patient health information: Male patient , child 10 years of age, . Clavamox dosage: . During the same period patient was treated with CEFPROZIL (View Cefprozil Review and Cefprozil Label ). Patient was hospitalized.

5397762-6 | Erythema Multiforme, Pyrexia
Adverse event was reported on Jul 20, 2007 by a Female patient taking Clavamox (View Usage) (Dosage: .7g Twice Per Day) was diagnosed with otitis media acute, nasopharyngitis, constipation (What is constipation?) and. Location: JAPAN , child 1 years of age, weighting 19.40 lb, Patient had the following side effects: erythema multiforme, pyrexia. During the same period patient was treated with ASVERIN (1.3ml Three Times Per Day) (View Asverin Review and Asverin Label ), BRICANYL (1ml Three Times Per Day) (View Bricanyl Review and Bricanyl Label ), TAVEGYL (1.3ml Three Times Per Day) (View Tavegyl Review and Tavegyl Label ), FLOMOX (.2g Three Times Per Day) (View Flomox Review and Flomox Label ), ONON (.3g Twice Per Day) (View Onon Review and Onon Label ), ZADITEN (.6ml Three Times Per Day) (View Zaditen Review and Zaditen Label ), BIOFERMIN R (.16g Three Times Per Day) (View Biofermin R Review and Biofermin R Label ), MUCODYNE (1.6ml Three Times Per Day) (View Mucodyne Review and Mucodyne Label ). Patient was hospitalized.

5378770-8 | Adverse Event, Loss Of Consciousness
on Jun 27, 2007 Male patient from PORTUGAL , 34 years of age, was treated with Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: adverse event, loss of consciousness. Clavamox dosage: . Patient was hospitalized.

5365549-6 | Erythema Multiforme, Pyrexia
on Jun 15, 2007 Female patient from JAPAN , child 1 years of age, weighting 19.40 lb, was diagnosed with otitis media acute, nasopharyngitis, constipation (What is constipation?) and was treated with Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme, pyrexia. Clavamox dosage: .7g Twice Per Day. During the same period patient was treated with ASVERIN (1.3ml Three Times Per Day) (View Asverin Review and Asverin Label ), BRICANYL (1ml Three Times Per Day) (View Bricanyl Review and Bricanyl Label ), TAVEGYL (1.3ml Three Times Per Day) (View Tavegyl Review and Tavegyl Label ), FLOMOX (.2g Three Times Per Day) (View Flomox Review and Flomox Label ), ONON (.3g Twice Per Day) (View Onon Review and Onon Label ), ZADITEN (.6ml Three Times Per Day) (View Zaditen Review and Zaditen Label ), BIOFERMIN R (.16g Three Times Per Day) (View Biofermin R Review and Biofermin R Label ), MUCODYNE (1.6ml Three Times Per Day) (View Mucodyne Review and Mucodyne Label ). Patient was hospitalized.

5350879-4 | Erythema Multiforme, Pyrexia
Patient was taking Clavamox (View Usage). Patient had the following side effects: erythema multiforme, pyrexia on Jun 05, 2007 from JAPAN Additional patient health information: Female patient , child 1 years of age, was diagnosed with otitis media acute and. Clavamox dosage: .7g Twice Per Day. During the same period patient was treated with MUCODYNE (View Mucodyne Review and Mucodyne Label ), ASVERIN (View Asverin Review and Asverin Label ), PERIACTIN (View Periactin Review and Periactin Label ). Patient was hospitalized.

5197156-2 | Dermatitis Allergic, Hyperthermia, Pyrexia, Rash
Adverse event was reported on Dec 21, 2006 by a Male patient taking Clavamox (View Usage) (Dosage: 10ml Per Day) . Location: PORTUGAL , child 2 years of age, After Clavamox was administered, patient had the following side effects: dermatitis allergic, hyperthermia, pyrexia, rash (What is rash?).

5175897-0 | Dermatitis Allergic, Hyperthermia, Pyrexia, Rash
on Dec 05, 2006 Male patient from PORTUGAL , child 2 years of age, was treated with Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis allergic, hyperthermia, pyrexia, rash (What is rash?). Clavamox dosage: 10ml Per Day.

5160287-7 | Decreased Appetite, Mouth Ulceration, Pyrexia
on Oct 27, 2006 Female patient from JAPAN , child 2 years of age, weighting 23.81 lb, was diagnosed with chalazion, infectious mononucleosis (What is infectious mononucleosis?), gastric ulcer and was treated with Clavamox (View Usage). Patient had the following side effects: decreased appetite, mouth ulceration, pyrexia. Clavamox dosage: . During the same period patient was treated with GATIFLO (View Gatiflo Review and Gatiflo Label ), FLOMOX (View Flomox Review and Flomox Label ), PREDONINE (10mg Per Day) (View Predonine Review and Predonine Label ), FAMOTIDINE (5mg Per Day) (View Famotidine Review and Famotidine Label ), LIDOMEX (View Lidomex Review and Lidomex Label ). Patient was hospitalized.

5157521-6 | Decreased Appetite, Infectious Mononucleosis, Mouth Ulceration, Pyrexia
Patient was taking Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: decreased appetite, infectious mononucleosis (What is infectious mononucleosis?), mouth ulceration, pyrexia on Oct 27, 2006 from JAPAN Additional patient health information: Female patient , child 2 years of age, weighting 23.81 lb, was diagnosed with chalazion, gastric ulcer and. Clavamox dosage: . During the same period patient was treated with GATIFLO (View Gatiflo Review and Gatiflo Label ), FLOMOX (View Flomox Review and Flomox Label ), FAMOTIDINE (5mg Per Day) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

5146889-2 | Urticaria
Adverse event was reported on Nov 02, 2006 by a Female patient taking Clavamox (View Usage) (Dosage: ) was diagnosed with tonsillitis and. Location: PORTUGAL , 39 years of age, Patient experienced the following unwanted or unexpected effects: urticaria. Patient was hospitalized.

5144085-6 | Infectious Mononucleosis
on Oct 27, 2006 Female patient from JAPAN , child 2 years of age, was diagnosed with chalazion and was treated with Clavamox (View Usage). Patient had the following side effects: infectious mononucleosis (What is infectious mononucleosis?). Clavamox dosage: . During the same period patient was treated with GATIFLO (View Gatiflo Review and Gatiflo Label ), FLOMOX (View Flomox Review and Flomox Label ). Patient was hospitalized.

5072641-2 | Erythema Multiforme, Gingival Swelling, Pigmentation Disorder, Rash, Swelling Face, Urticaria
on Jul 18, 2006 Male patient from JAPAN , child 7 years of age, weighting 68.34 lb, was diagnosed with otitis media, epilepsy (What is epilepsy?) and was treated with Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: erythema multiforme, gingival swelling, pigmentation disorder, rash (What is rash?), swelling face, urticaria. Clavamox dosage: . During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), BIOFERMIN R (View Biofermin R Review and Biofermin R Label ). Patient was hospitalized.

5071464-8 | Diarrhoea, Gastroenteritis, Gastrointestinal Hypermotility, Nausea
Patient was taking Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, gastroenteritis (What is gastroenteritis?), gastrointestinal hypermotility, nausea (What is nausea?) on Mar 10, 2006 from JAPAN Additional patient health information: Female patient , child 1 years of age, weighting 22.05 lb, was diagnosed with otitis media, rhinitis and. Clavamox dosage: .6g Twice Per Day. During the same period patient was treated with LL (3.6ml Per Day) (View Ll Review and Ll Label ), MUCODYNE (3.6ml Per Day) (View Mucodyne Review and Mucodyne Label ), CALONAL (View Calonal Review and Calonal Label ), LYSOZYME CHLORIDE (3.6ml Per Day) (View Lysozyme Chloride Review and Lysozyme Chloride Label ).

5065540-3 | Erythema Multiforme, Gingival Swelling, Pigmentation Disorder, Rash, Swelling Face, Urticaria
Adverse event was reported on Jul 18, 2006 by a Male patient taking Clavamox (View Usage) (Dosage: ) was diagnosed with otitis media, epilepsy (What is epilepsy?) and. Location: JAPAN , child 7 years of age, weighting 68.34 lb, Patient had the following side effects: erythema multiforme, gingival swelling, pigmentation disorder, rash (What is rash?), swelling face, urticaria. During the same period patient was treated with TEGRETOL (2u Per Day) (View Tegretol Review and Tegretol Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), BIOFERMIN R (View Biofermin R Review and Biofermin R Label ). Patient was hospitalized.

5052589-X | Erythema, Pruritus, Pyrexia, Rash
on Jun 14, 2006 Male patient from JAPAN , child 6 years of age, weighting 55.12 lb, was diagnosed with otitis media, streptococcal infection (What is streptococcal infection?), asthma (What is asthma?) and was treated with Clavamox (View Usage). After Clavamox was administered, patient had the following side effects: erythema, pruritus, pyrexia, rash (What is rash?). Clavamox dosage: 1.9g Twice Per Day. During the same period patient was treated with SAWACILLIN (250mg Three Times Per Day) (View Sawacillin Review and Sawacillin Label ), ZADITEN (1.5g Per Day) (View Zaditen Review and Zaditen Label ), FLOMOX (249mg Per Day) (View Flomox Review and Flomox Label ), BIOFERMIN R (3g Per Day) (View Biofermin R Review and Biofermin R Label ), ONON (100mg Per Day) (View Onon Review and Onon Label ), THEO DUR (120mg Per Day) (View Theo-dur Review and Theo-dur Label ), BISOLVON (8mg Per Day) (View Bisolvon Review and Bisolvon Label ), PERIACTIN (6mg Per Day) (View Periactin Review and Periactin Label ). Patient was hospitalized.

5023534-8 | Eyelid Oedema, Face Oedema, Urticaria Localised
on Jun 07, 2006 Female patient from PORTUGAL , child 8 years of age, was treated with Clavamox (View Usage). Patient experienced the following unwanted or unexpected effects: eyelid oedema, face oedema, urticaria localised. Clavamox dosage: . Patient was hospitalized.

5020078-4 | Dermatitis Exfoliative, Renal Failure Acute, Rhabdomyolysis
Patient was taking Clavamox (View Usage). Patient had the following side effects: dermatitis exfoliative, renal failure acute, rhabdomyolysis on May 30, 2006 from PORTUGAL Additional patient health information: Female patient , 30 years of age, was diagnosed with tooth infection, systemic lupus erythematosus and. Clavamox dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PROPANOLOL HYDROCHLORIDE (View Propanolol Hydrochloride Review and Propanolol Hydrochloride Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CAPTOPRIL (View Captopril Review and Captopril Label ). Patient was hospitalized.